Evidence map›Paper›PMID 18553126›Full record

ArticleJournal of pharmacokinetics and pharmacodynamics2008

Modeling time variant distributions of cellular lifespans: increases in circulating reticulocyte lifespans following double phlebotomies in sheep.

Kevin J Freise, John A Widness, Robert L Schmidt, Peter Veng-Pedersen

Open access · greenAbstract read
In one paragraph

Article in Journal of pharmacokinetics and pharmacodynamics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Models for the red blood cell lifespan.Journal of pharmacokinetics and pharmacodynamics · 2016
    Article
  5. Pharmacodynamic models of age-structured cell populations.Journal of pharmacokinetics and pharmacodynamics · 2015
    Review
  6. Article
  7. Article
  8. Solution and implementation of distributed lifespan models.Journal of pharmacokinetics and pharmacodynamics · 2013
    Article
  9. General relationship between transit compartments and lifespan models.Journal of pharmacokinetics and pharmacodynamics · 2012
    Article
  10. Lifespan based indirect response models.Journal of pharmacokinetics and pharmacodynamics · 2012
    Review
  11. Modeling red blood cell survival data.Journal of pharmacokinetics and pharmacodynamics · 2011
    Article
  12. Article
  13. Article
  14. Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants.The Journal of pharmacology and experimental therapeutics · 2010
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Kevin J FreiseCollege of Pharmacy, The University of Iowa, Iowa City, IA 52242, USA.
John A Widness
Robert L Schmidt
Peter Veng-Pedersen
University of Iowa · US

Funding

THE RoLE OF NEONATAL ANEMIA IN LEARNING AND MEMORYP01HL046925 · NHLBI · UNIVERSITY OF IOWA · PI SOLA-VISNER, MARTHA C. · 1992 to 2022
$34.3M
IN VIVO RECEPTOR BINDING OF BIOPHARMACEUTICALSR21GM057367 · NIGMS · UNIVERSITY OF IOWA · PI VENG-PEDERSEN, PETER · 1998 to 1999
–
NHLBI NIH HHS 2 P01 HL046925-11A1NHLBI NIH HHS P01 HL046925NIGMS NIH HHS R21 GM57367
6 · The paper itself

Abstract

Many pharmacodynamic (PD) models of cellular response assume a single and time invariant lifespan of all cells, despite the existence of a true underlying distribution of cellular lifespans and known changes in the lifespan distributions with time. To account for these features of cellular populations, a time variant cellular lifespan distribution PD model was formulated and theoretical aspects of modeling cellular populations presented. The model extends prior work assuming time variant "point distributions" of cellular lifespans (Freise et al. J Pharmacokinet Pharmacodyn 34:519-547, 2007) and models assuming a time invariant lifespan distribution (Krzyzanski et al. J Pharmacokinet Pharmacodyn 33:125-166, 2006). The formulated time variant lifespan distribution model was fitted to endogenous plasma erythropoietin (EPO), reticulocyte, and red blood cell (RBC) concentrations in sheep phlebotomized on two occasions, 8 days apart. The time variant circulating reticulocyte lifespan was modeled as a truncated and scaled Weibull distribution, with the location parameter of the distribution non-parametrically represented by an end constrained quadratic spline function. The formulated time variant lifespan distribution model was compared to the identical time invariant distribution, time variant "point distribution", and time invariant "point distribution" cellular lifespan models. Parameters of the time variant lifespan distribution model were well estimated with low standard errors. The mean circulating reticulocyte lifespan was estimated at 0.304 days, which rapidly increased over 3-fold following the first phlebotomy to a maximum of 1.03 days (P = 0.009). On average, the percentage of erythrocytes being released as reticulocytes maximally increased an estimated two-fold following the phlebotomies. The primary features of immature RBC physiology were captured by the model and gave results consistent with other estimates in sheep and humans. The comparison of the four lifespan models gave similar parameter estimates of the stimulation function and fits to the RBC data. However, the time invariant models fit the reticulocyte data poorly, while the time variant "point distribution" cellular lifespan model gave physiologically unrealistic estimates of the changes in the circulating reticulocyte lifespan under stress erythropoiesis. Thus the underlying physiology must be considered when selecting the most appropriate cellular lifespan model and not just the goodness-of-fit criteria. The proposed PD model and the numerical implementation allows for a flexible framework to incorporate time variant lifespan distributions when modeling populations of cells whose production or stimulation depends on endogenous growth factors and/or exogenous drugs.

Indexed as

AlgorithmsAnimalsBlood VolumeBody WeightCell CycleComputer SimulationErythrocyte CountErythrocytesErythroid Precursor CellsErythropoiesisErythropoietinModels, StatisticalPharmacokineticsPhlebotomyReticulocytesSheepErythropoietin

Identifiers

PMID18553126
PMCPMC2753503
OpenAlexW1965639324

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.